Metraipolis › archive › dc_da2162397027
Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application — Europe PMC PMID:42769931
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42769931
- DOI
- 10.1016/j.jscai.2026.105568
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T04:07:13.666Z
- SHA-256 of the archived text
e9f6a9f5e73ce5e635a3218921b4d3ef261604020e5620f053681e9e2ee856fb- Stable URL of this page
https://metraipolis.com/documento/dc_da2162397027
How to cite
Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application — Europe PMC PMID:42769931 — Europe PMC (en), https://europepmc.org/article/MED/42769931 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da2162397027 (Metraipolis archive dc_da2162397027, sha256 e9f6a9f5e73ce5e635a3218921b4d3ef261604020e5620f053681e9e2ee856fb)
BibTeX
@misc{dcda2162397027,
title = {Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application — Europe PMC PMID:42769931},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42769931},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da2162397027; sha256 e9f6a9f5e73ce5e635a3218921b4d3ef261604020e5620f053681e9e2ee856fb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42769931. Agents can read the archived copy with the MCP tool read_document.